$CTVA · Corteva, Inc.

Corteva, Inc. filed an 8-K announcing the SEC has declared effective Vylor's Form 10 registration statement, clearing the path for the spin-off of its seed and genetics business. The separation is expected to complete on October 1, 2026, with Corteva stockholders of record as of September 24, 2026 receiving one share of Vylor common stock for each Corteva share held. Vylor will trade on the NYSE under the symbol "VYLR" beginning October 1, 2026, with no when-issued or ex-distribution trading period.

Extended-hours trading shows CTVA at $79.19, down 0.33% from the regular close of $79.45 — a muted initial reaction to the spin-off confirmation. With a $53.14B market cap, the separation of Vylor represents a significant corporate restructuring, though the pro-rata distribution structure means no capital raise or dilution event.

A $53B+ market cap company completing a tax-free spin-off of a century-old seed/genetics business creates a new publicly traded entity and reshapes the agribusiness landscape.

Corteva joins a wave of agribusiness separations, following similar moves by peers to unlock value by splitting pure-play seed/genetics businesses from broader crop protection and digital ag platforms. Vylor's standalone listing creates a direct comp set with other publicly traded seed and genetics纯

The separation may adversely affect Corteva's ability to retain key personnel and maintain customer/supplier relationships. Unexpected costs from the separation process and potential litigation relating to the spin-off are also flagged. The Form 10 risk factors, as amended, contain additional risks.